Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce J Brew

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Current Opinion in Infectious Diseases|December 14, 2011
Neurocognitive dysfunction in the highly active antiretroviral therapy eraNomvuyo Z Mothobi, Bruce J Brew
AIDS (London, England)|December 3, 2019
The impact of HIV central nervous system persistence on pathogenesisBruce J Brew, Stephanie L Barnes
Journal of Neurovirology|January 13, 2019
Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigmLucette A Cysique, Bruce J Brew
Neuropsychology Review|May 9, 2009
Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a reviewLucette A Cysique, Bruce J Brew
Current Opinion in HIV and AIDS|May 30, 2014
The effects of HIV and aging on brain functions: proposing a research framework and update on last 3 years' findingsLucette A Cysique, Bruce J Brew
Current HIV/AIDS Reports|April 15, 2015
The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV EradicationAlessandro F Fois, Bruce J Brew
Redox Report : Communications in Free Radical Research|October 25, 2002
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's diseaseGilles J Guillemin, Bruce J Brew
Journal of Leukocyte Biology|November 13, 2003
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identificationGilles J Guillemin, Bruce J Brew
Journal of Neurovirology|February 26, 2004
Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?Bruce J Brew, Louise Pemberton, John Ray
AIDS (London, England)|April 18, 2003
Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathyBruce J Brew, Steve Tisch, Matthew Law
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Current Opinion in Infectious Diseases|December 14, 2011
Neurocognitive dysfunction in the highly active antiretroviral therapy eraNomvuyo Z Mothobi, Bruce J Brew
AIDS (London, England)|December 3, 2019
The impact of HIV central nervous system persistence on pathogenesisBruce J Brew, Stephanie L Barnes
Journal of Neurovirology|January 13, 2019
Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigmLucette A Cysique, Bruce J Brew
Neuropsychology Review|May 9, 2009
Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a reviewLucette A Cysique, Bruce J Brew
Current Opinion in HIV and AIDS|May 30, 2014
The effects of HIV and aging on brain functions: proposing a research framework and update on last 3 years' findingsLucette A Cysique, Bruce J Brew
Current HIV/AIDS Reports|April 15, 2015
The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV EradicationAlessandro F Fois, Bruce J Brew
Redox Report : Communications in Free Radical Research|October 25, 2002
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's diseaseGilles J Guillemin, Bruce J Brew
Journal of Leukocyte Biology|November 13, 2003
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identificationGilles J Guillemin, Bruce J Brew
Journal of Neurovirology|February 26, 2004
Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?Bruce J Brew, Louise Pemberton, John Ray
AIDS (London, England)|April 18, 2003
Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathyBruce J Brew, Steve Tisch, Matthew Law
Pageof 18